Survival analysis showed that CRC patients with high CXCL3, ELF5, and TIMP1 expression had a significantly shorter OS, whereas, for patients with low PHLPP2 expression, a longer OS was observed. This evidence concerns the gene ELF5 and colorectal carcinoma.